The Top Line cover image

Teva’s CEO shares ‘Pivot to Growth’ progress

The Top Line

00:00

Teva's Innovative Transformation

This chapter highlights Teva's strategic efforts to enhance its portfolio of innovative medicines, focusing on key products like Osteto and Ajovi. It emphasizes the company's commitment to addressing unmet medical needs in conditions such as tardive dyskinesia and schizophrenia, and discusses strategies to improve patient awareness and outcomes.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app